Results 221 to 230 of about 42,572 (273)

TLR9 gene polymorphism −1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population

Journal of Cancer Research and Clinical Oncology, 2017
The aim of this work was to evaluate the association of single nucleotide polymorphisms in TLR9 (-1486 T/C [rs187084], -1237T/C [rs5743836] and G2848A [rs352140]) with HPV infection, squamous intraepithelial lesions, and uterine cervical neoplasm in a Mexican population.
Cecilia Martínez-Campos, Margarita Bahena-Román, Kirvis Torres-Poveda, Ana I. Burguete-García, Vicente Madrid-Marina   +4 more
openaire   +3 more sources

Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays

Gynecologic Oncology, 2005
Cyclooxygenase-2 (COX-2) and c-erbB-2 are involved in the pathogenesis of solid organ tumors. Chemotherapeutic agents targeting COX-2 and c-erbB-2 are used to treat colon and breast cancers. This study evaluated the significance and relationship of COX-2 and c-erbB-2 protein expression in untreated uterine cervical neoplasm.This study included 332 ...
Jung Yeon Kim, Sung Jig Lim, Juree Kim, Chulmin Lee, Kyeongmee Park   +4 more
openaire   +3 more sources

[Treatment for recurrence of uterine cervical neoplasms].

Gan to kagaku ryoho. Cancer & chemotherapy, 2009
Naonori, Sakamoto, Ichio, Fukasawa, Noriyuki, Inaba   +2 more
openaire   +2 more sources

[Estimation of health-care costs for cervical uterine neoplasm].

Revista medica del Instituto Mexicano del Seguro Social, 2012
to value diagnostic stage and direct costs due to cervical cancer in insured workers and IMSS beneficiaries patients, during first year of treatment.80 records of patients with confirmed diagnosis of cervical cancer during 2000-2003 were analyzed. The study was made under provider public health services perspective, with focus in costs incidence during
Francisco Raúl, Sánchez-Román, Fernando, de Jesús Carlos-Rivera, Jorge Antonio, Guzmán-Caniupan, Pedro, Escudero-de Los Ríos, Cuauhtémoc Arturo, Juárez-Pérez, Guadalupe, Aguilar-Madrid   +5 more
openaire   +1 more source

An Outlook on Uterine Neoplasms: From Hormonal and DNA Damaging to Cervical and Endometrial Cancer Development and Minimally Invasive Management

2009
Uterine neoplasms are common tumors, formed by endometrial and cervical cancers; endometrial cancer is the fourth most frequently diagnosed cancer in developed countries and the eighth leading cause of cancer death in women, and cervical cancer is the second most common cancer in women worldwide and is a leading cause of cancer-related death in women ...
Tinelli A., Malvasi A., Lorusso V., Martignago R., VERGARA, DANIELE, VERGARI, UGHETTA, GUIDO, Marcello, Zizza A., Pisanò M., Leo G.   +9 more
openaire   +2 more sources

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

A Novel Brachytherapy Endoscopic Tandem and Inflatable Ovoids Applicator for Cervical and Uterine Neoplasms

International Journal of Radiation Oncology*Biology*Physics, 2020
openaire   +2 more sources

[I. Uterine cervical neoplasms 2. Strategy for treatment of adenocarcinoma in situ of uterine cervix and the role of chemotherapy ].

Gan to kagaku ryoho. Cancer & chemotherapy, 2012
Atsushi Hongo
openaire   +2 more sources

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung, Kimberly D Miller, Rebecca L Siegel   +2 more
exaly  

Colorectal cancer statistics, 2020

Ca-A Cancer Journal for Clinicians, 2020
Rebecca L Siegel, Kimberly D Miller, Stacey A Fedewa   +2 more
exaly